JAKARTA: Since the recent 10 years, pharmaceutical company PT Indofarma Tbk recorded profit amounting only to IDR1 billion in the first quarter of 2012.
The first quarter’s performance soared by 94.99% compared to that in the same period of 2011 hampering net loss by IDR19.99 billion. The great performance was triggered by higher sales realization by 52.54% to IDr180 billion from IDR118 billion in the first quarter of 2011.
The great achievement in recording income for the first quarter 2012 was also bolstered by the change of trade strategy run by the management, revealed Indofarma President Director Djakfarudin Junus.
In the second quarter this year, the net sales is projected to grow more than 20% compared to that of in the same period of 2011 at IDR323.86 billion.
Until the end of 2012, the sales realization may go to IDR1.4 trillion and net income to IDR74 billion. “Net margin is estimated to advance 5% from 3% today, while cost of goods sold is also targeted to 67.8% from 75% last year,” he said. (t01/aph)
>> MORE POPULAR ARTICLES: